First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
Aditi Vedi, Uri Ilan, Judith M. Boer, Bálint Egyed et al.
Journal
Haematologica
Topics
Acute Lymphoblastic Leukemia research
article
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
Aditi Vedi, Uri Ilan, Judith M. Boer, Bálint Egyed, Bodil Als-Nielsen, Mattias Hofmans, Monique L. den Boer, Birgit Geoerger, Maaike Luesink, M C Zwaan, Ruta Tuckuviene, Barbara De Moerloose, Frederik van Delft, Julie Irving, Alba Rubio, Pablo Velasco, Dániel J. Erdély, Jose Luis Fuster, Kjeld Schmiegelow, Sarah K. Tasian, Francisco Bautista, André Baruchel
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Semmelweis University (HU), Hebron University (PS), Children's Hospital of Philadelphia (US), Inserm (FR), Université Paris-Saclay (FR), Aalborg University Hospital (DK), Ghent University Hospital (BE), Institut Gustave Roussy (FR), Cambridge University Hospitals NHS Foundation Trust (GB), Rigshospitalet (DK), Hospital Infantil Universitario Niño Jesús (ES), Hôpital Robert-Debré (FR), Princess Máxima Center (NL), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Virgen de la Arrixaca (ES), Newcastle University (GB)
Funders
Amgen, Pfizer, Sanofi, Jazz Pharmaceuticals, BeiGene, Incyte, Syndax Pharmaceuticals, Novo Nordisk, Servier, Genentech, Daiichi Sankyo Europe